癌症中耐药性:分子机制和新兴治疗策略
Jinxin Li1, Jiatao Hu1, Yiren Yang1
1Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
Molecular biomedicine
|November 17, 2025
概括
癌症的治疗耐药性是一个主要的障碍. 本综述探讨了遗传,细胞和环境因素如何驱动耐药性,为长期控制癌症提供了新的策略.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 翻译医学是一种翻译医学.
背景情况:
- 治疗耐药性限制了癌症治疗的有效性,并导致复发.
- 了解耐药机制对于改善患者的治疗结果至关重要.
研究的目的:
- 系统地审查了解癌症耐药性的最新进展.
- 整合分子,细胞和生态因素,有助于抵抗.
- 概述新的治疗策略和未来的研究方向.
主要方法:
- 化学疗法,向疗法和免疫疗法耐药性的系统文献综述.
- 整合有关遗传改变,表观遗传重编程和瘤微环境的数据.
- 分析微生物组和先进的奥米克技术的新兴作用.
主要成果:
- 耐药性源于复杂的相互作用,包括遗传/表观遗传变化,代谢适应和瘤微环境.
- 微生物组成为影响治疗反应的关键因素.
- 新的策略利用抵抗机制作为弱点,采用合成致命性和代谢向.
结论:
- 一个统一的框架将克隆进化,代谢适应性和瘤生态联系在一起.
- 先进的奥米克和人工智能对于预测和管理阻力至关重要.
- 将机制性见解与适应性临床设计相结合,对于持续控制癌症至关重要.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.5K
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
14.3K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Cancer
53.4K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.4K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
